Joint DIA/ICOS Conference on Cardiac Toxicity 2014

Topics

• Best management approaches to protecting cardiac tissues during aggressive cancer therapy
• Best methods of cardiotoxicity detection during early phase clinical trials
• Effective communication between drug developers and prescribers
• Mechanistic actions of developing cancer therapy to allow cardioprotection
• Optimal patient care between cardiology and oncology

Who should Attend

• Drug development and clinical research managers and associates
• Cardiology, oncology and primary care physicians, nurse practioners, and other allied providers
• Pharmaceutical physicians and medical directors
• Pharmacovigilance, drug safety and drug surveillance personnel
• Clinical pharmacology scientists
• Safety pharmacology and non-clinical scientists
• Biostatisticians
• Regulatory affairs officers
• Outsourcing and marketing managers
• Data managers